According to the Zhitong Finance App, Kehua Biotech (002022.SZ) announced that the company has received the “Medical Device Registration Certificate” (in vitro diagnostic reagent) issued by the Shanghai Drug Administration. The product name is calcitonin determination kit (chemiluminescence) for medical institutions to quantitatively measure calcitonin (CT) concentration in human serum or plasma samples in vitro for auxiliary diagnosis.
科华生物(002022.SZ)：降钙素测定试剂盒(化学发光法)获得医疗器械注册证
Kehua Biotech (002022.SZ): Calcitonin determination kit (chemiluminescence method) obtained medical device registration certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.